Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Denali Therapeutics Inc
F:4DN
Denali Therapeutics Inc
F:4DN
Price:
16.89
EUR
-0.68%
Market Closed
Market Cap:
€2.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
D
|
Denali Therapeutics Inc
F:4DN
|
US |
|
Imperial Oil Ltd
TSX:IMO
|
CA |
|
A
|
Akastor ASA
DUS:KY7
|
NO |
|
CEZ as
PSE:CEZ
|
CZ |
|
Acacia Research Corp
NASDAQ:ACTG
|
US |
|
A
|
Altus SA
WSE:ALI
|
PL |
Wall St Price Targets
4DN Price Forecast
Based on 19 analysts
Based on 19 analysts
+39% Upside
from
€16.89
today
Denali Therapeutics Inc (4DN)’s 12-month stock price forecast through October 2027 has a consensus target of €23.52, implying 39% upside. The forecast is based on price targets from 19 Wall Street analysts.
4DN Analyst Rating
No ratings yet
No ratings yet
Denali Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 4DN's stock price target?
Price Target
23.52
EUR
23.52
EUR
According to Wall Street analysts, the average 1-year price target for 4DN is 23.52 EUR with a low forecast of 17.96 EUR and a high forecast of 29.05 EUR.